Skip to content

Clinical trials

Phase 3 Hepatitis B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 3 Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20061
20071
20081
20101
20121
20141
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bukwang Pharmaceutical3
GlaxoSmithKline3
GC Biopharma Corp1
Novartis1
Novartis Pharmaceuticals1
SK Chemicals Co., Ltd.1
Sanofi Pasteur, a Sanofi Company1
Seoul National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B12
Hepatitis B, Chronic3
Hepatitis2
Hepatitis, Chronic2
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Diphtheria1
HIV Infections1
Haemophilus Infections1
Hepatitis C1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.